Notice of 18th AGM of the Company.

SUPRIYA LIFESCIENCE LTD. " Creati11g true values that bind global l,ealtl, September 1, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir (s), Sub: Notice of the 18th Annual General Meeting, Annual Report FY 2025-26 and the Business Responsibility and Sustainability Report Further to our Letter dated August 26, 2026, convening that the 18th Annual General Meeting ("AGM") of the Members of the Company is scheduled to be held on Thursday, September 24, 2026, at 03:00 p.m. (IST) through Video Conferencing/ Other Audio Visual Means in accordance with relevant circulars issued by the Ministry of Corporate Affairs and SEBI. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2025-26 including the Business Responsibility and Sustainability Report, along with the Notice of AGM, which are being sent through electronic mode to the Members of the Company, whose email IDs are registered with Depositories/ Company/ Registrar and Share Transfer Agent. The Annual Report along with the Notice of the AGM for the Financial Year 2025-26 is also available on the website of the Company at www.supriyalifescience.com under “Investor Section”. The Notice of AGM of the Company inter alia indicates the process and manner of remote e-voting/ e- voting at the AGM and instructions for participating at the AGM through VC/OAVM. Kindly take the said information on your records. Thanking you, Yours faithfully, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE Annual Report 2025-26 CO FS Statutory Reports SR Notice Notice is Hereby given that the 18th Annual General Meeting (“AGM”) of Members of Supriya Lifescience Limited ‘(The Company’) will be held on Thursday, September 24, 2026 At 3:00 P.M. (IST) through Video Conferencing (“VC”)/Other Audio-Visual Means (“OAVM”) to Transact the following Business: ORDINARY BUSINESS: 1. To receive, consider, approve and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2026, and the reports of the Board of Directors and Auditors’ thereon. 2. To declare a Final Dividend of Re. 1.00/- (50%) per Equity Shares of ₹ 2/- for the Financial Year ended March 31, 2026. 3. To appoint a Director in place of Dr. Saloni Satish Wagh (DIN: 08491410) and Ms. Shivani Satish Wagh (DIN:08491420) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013, and being eligible, offers themselves for re-appointment. SPECIAL BUSINESS: 4. To ratify the remuneration of Cost Auditors for FY 2026-27 and, in this regard, to consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to provisions of Section 148 of the Companies Act, 2013 read with Rule 14 of the Companies (Audit and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and other applicable provisions, the remuneration of ₹ 2,50,000/- (Rupees Two Lakhs Fifty Thousand only) plus applicable tax and out-of-pocket expenses payable to M/s. Rampurawala Mohammed A & Co, Cost Accountants, having Firm Registration No. 003011, appointed by Board of Directors of the Company as Cost Auditors to conduct the audit of cost records of the Company for FY 2026-27 amounting to ₹ 2,50,000/- , be and is hereby ratified and confirmed.” Registered Office: By Order of the Board of Directors 207 /208, Udyog Bhavan, Sonawala Road, For Supriya Lifescience Limited Goregaon (East), Mumbai – 400063 Place: Mumbai Prachi Suhas Sathe Date: May 27, 2026 Company Secretary & Compliance Officer Supriya Lifescience Ltd. SUPRIYA LIFESCIENCE LTD. NOTES: 6. In line with the Ministry of Corporate Affairs (MCA) Circular No. 17/2020 dated April 13, 2020, the 1. Pursuant to the General Circular No. 03/2025 dated Notice calling the EGM/AGM has been uploaded September 22, 2025 (‘MCA Circulars’) and other on the website of the Company at https://www. applicable circulars and notifications issued (including supriyalifescience.com/. The Notice can also be any statutory modifications or re-enactment thereof accessed from the websites of the Stock Exchanges for the time being in force and as amended from time i.e. BSE Limited and National Stock Exchange of India to time, companies are allowed to hold EGM/AGM Limited at www.bseindia.com and www.nseindia. through Video Conferencing (VC) or other audio visual com respectively and the EGM/AGM Notice is also means (OAVM), without the physical presence of available on the website of NSDL (agency for providing members at a common venue. In compliance with the the Remote e-Voting facility) i.e. www.evoting.nsdl. said Circulars, EGM/AGM shall be conducted through com. VC / OAVM. 7. EGM/AGM has been convened through VC/OAVM 2. Pursuant to the Circular No. 14/2020 dated April 08, in compliance with applicable provisions of the 2020, issued by the Ministry of Corporate Affairs, Companies Act, 2013 read with MCA Circular issued the facility to appoint proxy to attend and cast vote from time to time. for the members is not available for this EGM/AGM. However, the Body Corporates are entitled to appoint 8. As per the provisions of Clause 3.A.II. of the General authorised representatives to attend the EGM/AGM Circular No. 20/2020 dated May 5, 2020, the matter through VC/OAVM and participate there at and cast of Special Business as appearing at Item Nos. 3 of the their votes through e-voting. accompanying Notice, is considered to be unavoidable by the Board and hence, forming part of this Notice. 3. The Members can join the EGM/AGM in the VC/OAVM mode 15 minutes before and after the scheduled time 9. The Company has fixed Friday, September 4, 2026 of the commencement of the Meeting by following as the “Record Date” for determining entitlement of the procedure mentioned in the Notice. The facility of Members to final dividend for the financial year ended participation at the EGM/AGM through VC/OAVM will March 31, 2026, if approved at the AGM. be made available for 1000 members on first come first served basis. This will not include large Shareholders 10. If the final dividend, as recommended by the Board of (Shareholders holding 2% or more shareholding), Directors, is approved at the AGM, will be paid subject Promoters, Institutional Investors, Directors, Key to deduction of tax at source, as applicable on or after Managerial Personnel, the Chairpersons of the Audit Thursday, September 24, 2026. Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee, Auditors 11. Pursuant to the provisions of Section 108 of the etc. who are allowed to attend the EGM/AGM without Companies Act, 2013 read with Rule 20 of the restriction on account of first come first served basis. Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing 4. The attendance of the Members attending the EGM/ Obligations & Disclosure Requirements) Regulations, AGM through VC/OAVM will be counted for the 2015 (as amended) and the Secretarial Standard on purpose of reckoning the quorum under Section 103 Genera [Showing first 8,000 characters — download PDF for full document]